Retinoblastoma is the most common pediatric intraocular malignancy and rarely presents with distant metastases. We present the case of a 6-y-old boy with unilateral retinoblastoma who developed ...
Journal of Nuclear Medicine Technology June 2026, jnmt.126.272275; DOI: https://doi.org/10.2967/jnmt.126.272275 ...
Prostate-specific membrane antigen (PSMA) has fundamentally reshaped prostate cancer imaging and therapy, delivering an unprecedented combination of high lesion conspicuity, broad clinical ...
Today’s common practice of empiric activity prescription in radiopharmaceutical therapy is inconsistent with the modern philosophy of personalized medicine. We investigate the radiobiologic ...
Prostate cancer is a rapidly expanding area for radiopharmaceutical therapy, primarily driven by prostate-specific membrane antigen–targeted imaging and therapy. This growth necessitates new workflows ...
The Prostate Cancer Working Group 4 guidelines (PCWG4) represent a significant evolution in the framework used to evaluate prostate cancer progression and treatment response in clinical trials.
Journal of Nuclear Medicine Technology April 2026, jnmt.126.272015; DOI: https://doi.org/10.2967/jnmt.126.272015 ...
Journal of Nuclear Medicine Technology March 2026, jnmt.125.271409; DOI: https://doi.org/10.2967/jnmt.125.271409 ...
The approval of disease-modifying antiamyloid therapies has expanded the clinical role of amyloid PET beyond diagnostic confirmation to include baseline characterization and longitudinal monitoring of ...
Journal of Nuclear Medicine Technology January 2026, jnmt.125.270563; DOI: https://doi.org/10.2967/jnmt.125.270563 ...
Journal of Nuclear Medicine Technology January 2026, jnmt.125.270526; DOI: https://doi.org/10.2967/jnmt.125.270526 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results